Orgenesis (NASDAQ:ORGS) reported quarterly earnings of $0.05 per share. This is a 88.1 percent decrease over earnings of $0.42 per share from the same period last year.
Champions Oncology Earnings Perspective: Return On Capital Employed
Champions Oncology (NASDAQ:CSBR) brought in sales totaling $13.07 million during Q4 according to data provided by Benzinga Pro.…